Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals.

OBJECTIVES To describe the methodology in developing an antimicrobial self-assessment toolkit (ASAT). METHODS The ASAT was developed through a National Pharmacy Reference Group using an evidence-based approach of published information and national reports to identify criteria for inclusion. These were subdivided into domains that addressed: 1) Antimicrobial management within the Trust-structures and lines of responsibility and accountability-high-level notification to the Board. 2) Operational delivery of an antimicrobial strategy-operational standards of good antimicrobial stewardship. 3) Risk assessment for antimicrobial chemotherapy. 4) Clinical governance assurance. 5) Education and training-training needs and delivery of education and training for all who issue, prescribe and administer antimicrobials. 6) Antimicrobial pharmacist-systems in place for ensuring their optimum use. 7) Patients, Carers and the Public-information needs of patients, carers and the public. RESULTS A web-based toolkit was developed using information from national reports and guidance on antimicrobial stewardship. The toolkit offers a checklist for hospitals to self-assess their organizations' levels of antimicrobial stewardship. CONCLUSIONS The ASAT offers a web-enabled, version-controlled instrument for the assessment of antimicrobial stewardship in acute hospitals. It may offer a sensitive instrument to assess longitudinal progress on antimicrobial stewardship in an individual institution or act as a benchmark with similar organizations. Further work is ongoing to evaluate and further refine the ASAT.

[1]  Jane M. Young,et al.  Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[2]  Sharon Begley,et al.  The best medicine. , 2011, Scientific American.

[3]  P. Bonnabry,et al.  Temporal effects of antibiotic use and Clostridium difficile infections. , 2009, The Journal of antimicrobial chemotherapy.

[4]  A. Robinson,et al.  You’re Welcome quality criteria: making health services young-people-friendly , 2009, Sexually Transmitted Infections.

[5]  P. Astagneau,et al.  Specific control measures for antibiotic prescription are related to lower consumption in hospitals: results from a French multicentre pilot study. , 2008, The Journal of antimicrobial chemotherapy.

[6]  Jane W. Marsh,et al.  Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  P. Davey,et al.  Improving practice--working together to improve the use of antimicrobials. , 2007, The Journal of antimicrobial chemotherapy.

[8]  K. Hand Antibiotic pharmacists in the ascendancy. , 2007, The Journal of antimicrobial chemotherapy.

[9]  P. Davey,et al.  Professional education on antimicrobial prescribing: a report from the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Professional Education Subgroup. , 2007, The Journal of antimicrobial chemotherapy.

[10]  J. Cooke Report of the Prescribing Subgroup of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR). , 2007, The Journal of antimicrobial chemotherapy.

[11]  J. Cooke Achieving prudence in the prescribing of antimicrobials--using clinical pharmacists in English acute hospitals. , 2007, The Journal of hospital infection.

[12]  B S Cooper,et al.  Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. , 2007, The Journal of antimicrobial chemotherapy.

[13]  I. Gyssens,et al.  Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  H. Goossens,et al.  Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study , 2007, The Lancet.

[15]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  A. Jacklin,et al.  Impact of the Hospital Pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England. , 2006, The Journal of antimicrobial chemotherapy.

[17]  J. Lammers,et al.  Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial , 2006, BMJ : British Medical Journal.

[18]  D. Nathwani Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals. , 2006, The Journal of antimicrobial chemotherapy.

[19]  C. Ramsay,et al.  Systematic Review of Antimicrobial Drug Prescribing in Hospitals , 2006, Emerging infectious diseases.

[20]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[21]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[22]  L. Lanthier,et al.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  K. Sepkowitz,et al.  Risk Factors for Acquisition of Clostridium difficile–Associated Diarrhea among Outpatients at a Cancer Hospital , 2005, Infection Control & Hospital Epidemiology.

[24]  P. Davey,et al.  An outcome-based approach for teaching prudent antimicrobial prescribing to undergraduate medical students: report of a Working Party of the British Society for Antimicrobial Chemotherapy. , 2005, The Journal of antimicrobial chemotherapy.

[25]  D. Livermore,et al.  Minimising antibiotic resistance. , 2005, The Lancet. Infectious diseases.

[26]  E. P. Dellinger,et al.  Hospitals collaborate to decrease surgical site infections. , 2005, American journal of surgery.

[27]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[28]  M. Muscat,et al.  Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. , 2004, The Journal of antimicrobial chemotherapy.

[29]  Louis Valiquette,et al.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.

[30]  Av Bugnon-Reber,et al.  Antibiotic misuse in medium-sized Swiss hospitals. , 2004, Swiss medical weekly.

[31]  M. Wilcox,et al.  Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.

[32]  R. Gaynes,et al.  Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  J M Grimshaw,et al.  Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.

[34]  Peter Davey,et al.  Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. , 2003, The Journal of antimicrobial chemotherapy.

[35]  Norma Terrin,et al.  Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years , 2003, Infection Control & Hospital Epidemiology.

[36]  J. Cheesbrough,et al.  Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. , 2003, The Journal of hospital infection.

[37]  M. Stevenson,et al.  Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. , 2003, The Journal of antimicrobial chemotherapy.

[38]  T. Ozawa,et al.  Clostridium difficile infection associated with levofloxacin treatment. , 2002, Tennessee medicine : journal of the Tennessee Medical Association.

[39]  J. Ramirez,et al.  Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. , 2001, Archives of internal medicine.

[40]  M. S. Richards,et al.  Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. , 2001, Archives of internal medicine.

[41]  Clara C. Pratt,et al.  Measuring Program Outcomes: Using Retrospective Pretest Methodology , 2000 .

[42]  S. Stone,et al.  Feedback is necessary in strategies to reduce hospital acquired infection , 2000, BMJ : British Medical Journal.

[43]  S. S. Leger Quick fixes for research assessment exercise will not work , 2000 .

[44]  J. V. D. van der Meer,et al.  Antibiotic use in Dutch hospitals 1991-1996. , 2000, The Journal of antimicrobial chemotherapy.

[45]  G E Bignardi,et al.  Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.

[46]  A. Moore,et al.  Antimicrobial associations of an outbreak of diarrhoea due to Clostridium difficile. , 1998, The Journal of hospital infection.

[47]  P. Coudron,et al.  Hospital-wide Restriction of Clindamycin: Effect on the Incidence of Clostridium difficile-Associated Diarrhea and Cost , 1998, Annals of Internal Medicine.

[48]  T. Clemmer,et al.  A computer-assisted management program for antibiotics and other antiinfective agents. , 1998, The New England journal of medicine.

[49]  R N Baldwin,et al.  Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. , 1997, The Journal of antimicrobial chemotherapy.

[50]  D. Gerding,et al.  Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.

[51]  David C. Classen,et al.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. , 1992, The New England journal of medicine.

[52]  R. Fritz The Path of Least Resistance , 1986 .

[53]  J. Cooke,et al.  Clostridium difficile infection: how to deal with the problem , 2009 .

[54]  Clostridium difficile infection: how to deal with the problem , 2009 .

[55]  A D Oxman,et al.  Audit and feedback: effects on professional practice and health care outcomes. , 2006, The Cochrane database of systematic reviews.

[56]  Jim Smith,et al.  Building a safer NHS for patients: improving medication safety , 2004 .

[57]  C. Normand,et al.  A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.

[58]  B. Tennison,et al.  Commission for Healthcare Audit and Inspection , 2004 .

[59]  L. Donaldson Getting Ahead of the Curve. A strategy for combating infectious diseases (including other aspects of health protection) , 2002 .

[60]  Winning Ways Working together to reduce Healthcare Associated Infection in England Report from the Chief Medical Officer December 2003 , 2022 .